kras mutation and glutathion Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Targeting mutated GTPase KRAS in
Targeting mutated GTPase KRAS in tumor therapies ScienceDirect The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis Cell Death & Disease
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20





